Hospital pharmacy response to the COVID-19 pandemic: experience from a regional referral center in the United Arab Emirates

Author:

Hammad MuhammadORCID,Tashtoush Mohammad Mousa,El Faki El Mutasim Ahmed,Hajaj Marwa Yousif,Ahmed Saima Saeed,Darwish Amal Ahmed

Abstract

Abstract Background The recent SARS‐CoV‐2 pandemic has resulted in significant morbidity and mortality worldwide. The healthcare systems, including pharmacies, faced unique challenges, such as managing  an overwhelming patient influx, clinical workforce management, transitioning to remote or online work, medication procurement and several others. The purpose of this study is to describe our hospital pharmacy’s experience dealing with the COVID-19 pandemic and to present solutions to the challenges that arose. Methodology We retrospectively reviewed and consolidated strategies, interventions, and solutions that were implemented by our pharmaceutical institute in response to the challenges that arose during the COVID-19 pandemic. The study period was from March 1 to September 30, 2020. Results We reviewed and organized our hospital pharmacy response to the COVID-19 pandemic into different categories. In inpatient and outpatient satisfaction surveys, physicians and patients expressed a high level of satisfaction with pharmacy services. The close collaboration between the pharmacy team and other clinicians was demonstrated through the number of pharmacist interventions, participation in the COVID-19 guidelines reviews, involvement in local and international research, and innovative solutions to inpatient and outpatient pharmacy medication management challenges. Conclusions This study highlights the crucial role that our pharmacists and pharmaceutical institute played in ensuring continuity of care during the COVID-19 pandemic. We implemented several key initiatives, innovations, and collaborations with other clinical disciplines to successfully overcome the challenges faced.

Publisher

Informa UK Limited

Subject

Pharmacy,Health Policy

Reference36 articles.

1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33.

2. WHO. WHO coronavirus disease (COVID-19) dashboard | WHO coronavirus disease (COVID-19) dashboard. Who.int. 2022. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200312-sitrep-52-covid-19.pdf?sfvrsn=e2bfc9c0_4.

3. World Health Organization. WHO coronavirus (COVID-19) dashboard. covid19.who.int. 2022. https://covid19.who.int/. Accessed 6 May 2022.

4. National Emergency Crisis and Disaster Management Authority. UAE coronavirus (COVID-19) updates. 2022. https://covid19.ncema.gov.ae/en.

5. World Health Organization. Interim clinical guidance for management of patients with confirmed coronavirus disease (COVID-19). Centers Dis Control Prev. 2020;2019.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3